Withania somnifera in Women’s Hormonal Modulation: A Narrative Review With Implications for Polycystic Ovary Syndrome and Premenstrual Syndrome
Ashwagandha rises as a strong candidate for supportive treatment for managing the symptoms of PCOS and PMS by means of combined hormonal, metabolic, and neuropsychiatric effects. However, as current evidence relies heavily on preclinical models and extrapolation from other populations, further large-scale, randomized clinical trials using standardized extracts are necessary to establish definitive therapeutic protocols and confirm its clinical efficacy and safety.
Authors
- Ewa Majcherek (ORCID: https://orcid.org/0000-0001-5682-2079)
- Jan Haraj (ORCID: https://orcid.org/0009-0007-4847-6576)
- Sandra Dachowska (ORCID: https://orcid.org/0009-0009-0828-3053)
- Kinga Woźniak
- Maria Namysł
- Marcin Sobkowiak
- Simon Matczak
- Maciej Bieniek
Institutions
- Poznan University of Medical Sciences (PL)
Publication Details
- Journal
- Cureus
- Published
- 2026-01-13
- DOI
- https://doi.org/10.7759/cureus.101431
- Primary Topic
- Phytochemicals and Medicinal Plants
- Type
- article
- Field-Weighted Citation Impact
- 0.00